Transvaginal Ultrasound-Guided Ovarian Interstitial Laser Treatment in Anovulatory Women with Polycystic Ovarian Syndrome: a Randomized Clinical Trial on the Effect of Laser Dose Used on the Outcome
Zhu Wen-feng,Zhi-hong Fu,X.-M. Chen,X.-M. Li,Zesheng Tang
DOI: https://doi.org/10.1016/j.fertnstert.2008.07.216
IF: 6.7
2008-01-01
Fertility and Sterility
Abstract:OBJECTIVE: A new effective way, transvaginal ultrasound-guided ovarian interstitial laser-coagulation treatment, in management of anovulation in patients with polycystic ovary syndrome (PCOS), has been presented in the data published. But, the optimal number of laser coagulation points in the ovarian interstitial to be applied at the procedure is unclear. This clinic trial aims to explore an optimal laser dose for this new procedure.DESIGN: A randomized clinical trial.MATERIALS AND METHODS: Fifty-six PCOS women with clomifene citrate-resistant underwent ultrasound-guided transvaginal ovarian interstitial YAG-laser treatment. By random list table, all subjects were randomly divided into four groups in terms of the number of laser coagulation points made in their ovaries as follows: group A, one coagulation point per ovary; group B, two points; group C, three points; group D, four to five points. The size of each point was about 10 mm in diameter on the ovarian plane monitored by transvagial ultrasound. Postoperative ovulation rate, pregnancy rate and some biochemical parameters were compared among four groups.RESULTS: The rates of ovulation in group C (71.43%, 95% CI:42%, 92%) and D (78.57%, 95% CI:49%, 95%) within six postoperative months were significantly higher than in group A (0.00%, 95% CI: 0%, 23%) (P<0.001; P<0.001) and B (28.57%, 95% CI:8%, 58%) (P<0.05; P<0.01). The pregnancy rate in group C (42.86%, 95% CI:18%,71%) and D (35.71%, 95% CI:13%, 65%) were also significantly higher than in group A (0.00%,95% CI:0%, 23%) (P<0.01; P<0.05). The mean serum testosterone levels were significantly lower in group C (2.18±0.29 nmol/l, 95%CI: 2.07 nmol/l, 2.08 nmol/l) and D (2.07±0.21 nmol/l, 95% CI: 1.98nmol/l, 2.15 nmol/l) compared with group A(3.53±0.59 nmol/l, 95% CI: 3.74 nmol/l,4.12 nmol/l) (P<0.01; P<0.01) and B(3.31±0.51 nmol/l, 95%CI: 3.13 nmol/l, 3.47 nmol/l)(P<0.01; P<0.01); There were no significant differences between group A and B or group C and D in these parameters.CONCLUSIONS: One and two intraovarian laser coagulation points per ovary are associated with poor results. Three points per ovary seem to represent the plateau of effective dose for the ovarian interstitial laser treatment. OBJECTIVE: A new effective way, transvaginal ultrasound-guided ovarian interstitial laser-coagulation treatment, in management of anovulation in patients with polycystic ovary syndrome (PCOS), has been presented in the data published. But, the optimal number of laser coagulation points in the ovarian interstitial to be applied at the procedure is unclear. This clinic trial aims to explore an optimal laser dose for this new procedure. DESIGN: A randomized clinical trial. MATERIALS AND METHODS: Fifty-six PCOS women with clomifene citrate-resistant underwent ultrasound-guided transvaginal ovarian interstitial YAG-laser treatment. By random list table, all subjects were randomly divided into four groups in terms of the number of laser coagulation points made in their ovaries as follows: group A, one coagulation point per ovary; group B, two points; group C, three points; group D, four to five points. The size of each point was about 10 mm in diameter on the ovarian plane monitored by transvagial ultrasound. Postoperative ovulation rate, pregnancy rate and some biochemical parameters were compared among four groups. RESULTS: The rates of ovulation in group C (71.43%, 95% CI:42%, 92%) and D (78.57%, 95% CI:49%, 95%) within six postoperative months were significantly higher than in group A (0.00%, 95% CI: 0%, 23%) (P<0.001; P<0.001) and B (28.57%, 95% CI:8%, 58%) (P<0.05; P<0.01). The pregnancy rate in group C (42.86%, 95% CI:18%,71%) and D (35.71%, 95% CI:13%, 65%) were also significantly higher than in group A (0.00%,95% CI:0%, 23%) (P<0.01; P<0.05). The mean serum testosterone levels were significantly lower in group C (2.18±0.29 nmol/l, 95%CI: 2.07 nmol/l, 2.08 nmol/l) and D (2.07±0.21 nmol/l, 95% CI: 1.98nmol/l, 2.15 nmol/l) compared with group A(3.53±0.59 nmol/l, 95% CI: 3.74 nmol/l,4.12 nmol/l) (P<0.01; P<0.01) and B(3.31±0.51 nmol/l, 95%CI: 3.13 nmol/l, 3.47 nmol/l)(P<0.01; P<0.01); There were no significant differences between group A and B or group C and D in these parameters. CONCLUSIONS: One and two intraovarian laser coagulation points per ovary are associated with poor results. Three points per ovary seem to represent the plateau of effective dose for the ovarian interstitial laser treatment.